MEI Pharma, Inc.MEIP

Market cap
$18.72M
P/E ratio
Jun 30,
2012
Jun 30,
2013
Jun 30,
2014
Jun 30,
2015
Jun 30,
2016
Jun 30,
2017
Jun 30,
2018
Jun 30,
2019
Jun 30,
2020
Jun 30,
2021
Jun 30,
2022
Jun 30,
2023
Net loss-8-11-----40-17-46-51-54-32
Change in fair value of warrant liability-------1028-2318212
Share-based compensation3454323771084
Non-cash lease expense----------11
Issuance of warrants-----------1
Depreciation and amortization-00000000000
Non-cash lease expense----------11
Impairment of intangible assets--------0---
Depreciation and amortization-00000000000
Unbilled Receivables----------2-10
Receivable for foreign tax withholding---------2020--
Prepaid expenses and other current assets000001-013103
Prepaid expenses and other current assets000001-013103
Accounts payable111-10-031-242-2
Accounts payable111-10-031-242-2
Accrued liabilities11210-1011222
Accrued liabilities11210-1011222
Deferred revenue-------775516-31
Deferred revenue-------775516-31
Operating lease liability---------1-1-1
Operating lease liability---------1-1-1
Net cash used in operating activities-7-10-----21-2934-32-49-52
Purchases of property and equipment000000-01100
Purchases of short-term investments--3570556011465190420273102
Proceeds from maturity of short-term investments---606550708985446280155
Net cash provided by investing activities-0-0-----4424-10625754
Proceeds from Issuance of Common Stock871263343-4----52-
Payment of issuance costs----------4-
Proceeds from Stock Options Exercised------00001-
Payments of tax withholdings related to vesting of restricted stock units-------0--00
Proceeds From Previously Issued Common Stock--------5---
Net cash (used in) provided by financing activities87127----70175349-0
Net cash (used in) provided by financing activities87127----70175349-0
Net increase in cash and cash equivalents--------3-471
Income taxes paid-0-0-0-0-0-0-0-0-0-0--
Right-of-Use Asset Obtained in Exchange for Operating Lease Liability---------924
Right-of-Use Asset Obtained in Exchange for Operating Lease Liability---------924
Warrants issued pursuant to cashless exercise---------0--